Gust Van Olmen

1.2k total citations · 1 hit paper
9 papers, 894 citations indexed

About

Gust Van Olmen is a scholar working on Surgery, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gust Van Olmen has authored 9 papers receiving a total of 894 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 4 papers in Genetics and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gust Van Olmen's work include Inflammatory Bowel Disease (4 papers), Gastrointestinal disorders and treatments (2 papers) and Autoimmune and Inflammatory Disorders (2 papers). Gust Van Olmen is often cited by papers focused on Inflammatory Bowel Disease (4 papers), Gastrointestinal disorders and treatments (2 papers) and Autoimmune and Inflammatory Disorders (2 papers). Gust Van Olmen collaborates with scholars based in Belgium, Netherlands and South Korea. Gust Van Olmen's co-authors include Geert D’Haens, Séverine Vermeire, Isolde Aerden, Maja Noman, Gert Van Assche, Paul Rutgeerts, Marc Ferrante, Filip Baert, Liesbeth Moortgat and Patricia Geens and has published in prestigious journals such as Gastroenterology, Gastrointestinal Endoscopy and Inflammatory Bowel Diseases.

In The Last Decade

Gust Van Olmen

8 papers receiving 879 citations

Hit Papers

Fecal calprotectin is a surrogate marker for endoscopic l... 2012 2026 2016 2021 2012 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gust Van Olmen Belgium 6 756 641 394 101 98 9 894
Urpo Nieminen Finland 12 453 0.6× 423 0.7× 324 0.8× 86 0.9× 96 1.0× 20 696
Patricia Geens Belgium 5 557 0.7× 467 0.7× 287 0.7× 97 1.0× 81 0.8× 11 681
Lajos S. Kiss Hungary 17 811 1.1× 708 1.1× 383 1.0× 96 1.0× 50 0.5× 34 981
TM Bayless United States 7 517 0.7× 334 0.5× 256 0.6× 106 1.0× 68 0.7× 10 610
Eran Zittan Israel 15 586 0.8× 456 0.7× 314 0.8× 135 1.3× 42 0.4× 41 742
Isolde Aerden Belgium 12 1.5k 2.0× 1.1k 1.8× 821 2.1× 197 2.0× 146 1.5× 21 1.8k
U. Monsén Sweden 11 497 0.7× 388 0.6× 270 0.7× 95 0.9× 68 0.7× 12 632
G. Vernier‐Massouille France 8 393 0.5× 299 0.5× 265 0.7× 83 0.8× 39 0.4× 12 590
Sheila Viola France 8 399 0.5× 391 0.6× 273 0.7× 108 1.1× 265 2.7× 10 665
Sari Iltanen Finland 15 403 0.5× 631 1.0× 408 1.0× 117 1.2× 488 5.0× 19 905

Countries citing papers authored by Gust Van Olmen

Since Specialization
Citations

This map shows the geographic impact of Gust Van Olmen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gust Van Olmen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gust Van Olmen more than expected).

Fields of papers citing papers by Gust Van Olmen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gust Van Olmen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gust Van Olmen. The network helps show where Gust Van Olmen may publish in the future.

Co-authorship network of co-authors of Gust Van Olmen

This figure shows the co-authorship network connecting the top 25 collaborators of Gust Van Olmen. A scholar is included among the top collaborators of Gust Van Olmen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gust Van Olmen. Gust Van Olmen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Cuyle, Pieter‐Jan, Veerle Moons, Gust Van Olmen, et al.. (2019). Molecular detection of Helicobacter pylori and clarithromycin resistance in gastric biopsies: a prospective evaluation of RIDA®GENE Helicobacter pylori assay. Acta Clinica Belgica. 76(3). 177–183. 14 indexed citations
2.
Smismans, Annick, Gust Van Olmen, Geert D’Haens, et al.. (2013). P278 Clinical comparison of eight different calprotectin immunoassays for the diagnosis and follow-up of inflammatory bowel disease. Journal of Crohn s and Colitis. 7. S120–S120. 1 indexed citations
3.
D’Haens, Geert, Marc Ferrante, Séverine Vermeire, et al.. (2012). Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease. Inflammatory Bowel Diseases. 18(12). 2218–2224. 628 indexed citations breakdown →
4.
Bossuyt, Peter, et al.. (2011). Single-centre experience on use of videocapsule endoscopy for obscure gastrointestinal bleeding in 120 consecutive patients.. PubMed. 74(3). 400–6. 2 indexed citations
5.
Buchel, Otto C., et al.. (2008). Endoscopic trimming of metallic stents with the use of argon plasma. Gastrointestinal Endoscopy. 67(2). 369–371. 18 indexed citations
6.
D’Haens, Geert, Séverine Vermeire, Gert Van Assche, et al.. (2008). Therapy of Metronidazole With Azathioprine to Prevent Postoperative Recurrence of Crohn's Disease: A Controlled Randomized Trial. Gastroenterology. 135(4). 1123–1129. 214 indexed citations
7.
Noman, Maja, et al.. (2007). Combination therapy with metronidazole and azathioprine reduces severe postoperative recurrence of Crohn's disease: A double-blind controlled randomized trial. Gastroenterology. 132(4). 5 indexed citations
9.
Olmen, Gust Van, Raymond Verhaeghe, & W. Pelemans. (1985). [Gastrointestinal hemorrhage in an aged subject with an aortic prosthesis].. PubMed. 16(4). 155–7.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026